remdesivir was identified as a possible treatment for the Ebola virus. 
the department of defense paid Gilead to develop it, to the tune of $34.5 million today. 
remdesivir NIH also sunk $30 million into the clinical trial to observe how remdesivir acted against COVID-19 earlier this spring. 
remdesivir was identified as a possible treatment for the Ebola virus, but is struggling with the maintenance.
..........................................................................................................